Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age Women
Table 1
PCOS diagnostic criteria, adapted from Teede et al. 2010 [5].
NIH 1990
Rotterdam 2003
AE-PCOS Society 2006
Both of the following*: (i) chronic anovulation, documented by oligo-or amenorrhea (ii) clinical and/or biochemical signs of hyperandrogenism (with exclusion of other etiologies, e.g., congenital adrenal hyperplasia) with or without PCO on ultrasound
At least two of the following*: (i) chronic anovulation, documented by oligo-or amenorrhea (ii) clinical and/or biochemical signs of hyperandrogenism (iii) polycystic ovaries (by ultrasound)
(i) Clinical and/or biochemical signs of hyperandrogenism and at least one of the following*: (i) ovarian dysfunction (oligo/anovulation and/or polycystic ovarian morphology)
*After exclusion of the diseases that produce a similar clinical picture.